Skip to content
MedsAcross

Medicine

Estradiol 0.5 mg tablet

Estradiol · Oral
Available on requestPrescription onlyUS FDAGeneric name

Estradiol 0.5 mg tablet is a generic prescription medicine for oral use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…

Key facts

Active ingredient (INN)
Estradiol
Brand
Sold under the generic name
Strength
0.5 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 30 tablets and 33 more
Manufacturers
Bryant Ranch PrepackA-S Medication SolutionsPreferred PharmaceuticalsAsclemedEpic PharmaNorthwind HealthPuraCap LaboratoriesANI PharmaceuticalsCouplerDirect_Rx
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
G03CA03 Estradiol
HS code (indicative)
3004.39Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
28 October 1997
Identifiers
RxCUI 197657, 197658, 197659DailyMed set ID 47e446f8-ac16-ea6b-e063-6394a90a1726, 97ace322-341a-4d52-8c63-17265ed9aa8d, 3fe899db-a8cd-4a31-88fb-1129be96b4d9 +15NDC 72189-655, 24658-702, 70954-564 +14Application ANDA217334, ANDA040275, ANDA040197

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle70954-564-10ANI Pharmaceuticals6 September 2023
100 tablet in 1 bottle42806-087-01Epic Pharma10 April 2017
500 tablet in 1 bottle42806-087-05Epic Pharma10 April 2017
100 tablet in 1 bottle24658-702-01Puracap Laboratories10 September 2021
500 tablet in 1 bottle24658-702-05Puracap Laboratories10 September 2021
100 tablet in 1 bottle0555-0899-02Teva Pharmaceuticals28 October 1997
100 tablet in 1 bottle63629-8802-1Bryant Ranch Prepack4 April 2024
30 tablet in 1 bottle71335-0226-1Bryant Ranch Prepack29 June 2018
100 tablet in 1 bottle71335-0226-2Bryant Ranch Prepack27 December 2021
90 tablet in 1 bottle71335-0226-3Bryant Ranch Prepack7 May 2018
60 tablet in 1 bottle71335-0226-4Bryant Ranch Prepack27 December 2021
30 tablet in 1 bottle71335-0430-1Bryant Ranch Prepack4 September 2015
100 tablet in 1 bottle71335-0430-2Bryant Ranch Prepack4 September 2015
90 tablet in 1 bottle71335-0430-3Bryant Ranch Prepack4 September 2015
60 tablet in 1 bottle71335-0430-4Bryant Ranch Prepack4 September 2015
30 tablet in 1 bottle71335-2892-1Bryant Ranch Prepack28 October 2025
100 tablet in 1 bottle71335-2892-2Bryant Ranch Prepack28 October 2025
90 tablet in 1 bottle71335-2892-3Bryant Ranch Prepack28 October 2025
60 tablet in 1 bottle71335-2892-4Bryant Ranch Prepack28 October 2025
30 tablet in 1 bottle50090-1882-0A-S Medication Solutions16 June 2015
90 tablet in 1 bottle50090-1882-1A-S Medication Solutions20 February 2019
30 tablet in 1 bottle50090-5494-0A-S Medication Solutions17 March 2021
90 tablet in 1 bottle50090-5494-1A-S Medication Solutions17 March 2021
100 tablet in 1 bottle76420-021-10Asclemed29 September 2020
30 tablet in 1 bottle76420-021-30Asclemed16 December 2019
90 tablet in 1 bottle76420-021-90Asclemed16 December 2019
30 tablet in 1 blister pack67046-1568-3Coupler17 June 2025
60 tablet in 1 bottle72189-655-60Direct_Rx8 January 2026
100 tablet in 1 bottle72603-273-01NorthStar Rx10 July 2024
90 tablet in 1 bottle, plastic51655-860-26Northwind Health4 May 2023
30 tablet in 1 bottle, plastic51655-860-52Northwind Health9 February 2023
30 tablet in 1 bottle, plastic72789-489-30PD-Rx Pharmaceuticals20 February 2025
100 tablet in 1 bottle68788-8626-1Preferred Pharmaceuticals9 April 2024
30 tablet in 1 bottle68788-8626-3Preferred Pharmaceuticals9 April 2024
60 tablet in 1 bottle68788-8626-6Preferred Pharmaceuticals9 April 2024
90 tablet in 1 bottle68788-8626-9Preferred Pharmaceuticals9 April 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 10 September 1986Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Estradiol

Clinical summary

Estradiol is an estrogen indicated for climara is an estrogen indicated for, among other approved uses. It is available as transdermal patches, tablets and gel for oral and topical use. MedsAcross supplies Estradiol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Estradiol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Estradiol 0.5 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.